Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 30, 2026.

Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies – a comprehensive review

Raj Kumar Singh, Kuldeep Dhama, Sandip Chakraborty and 11 more

Veterinary Quarterly · 2019 · Review · CC BY

doi:10.1080/01652176.2019.1580827

Abstract

Nipah (Nee-pa) viral disease is a zoonotic infection caused by Nipah virus (NiV), a paramyxovirus belonging to the genus Henipavirus of the family Paramyxoviridae. It is a biosafety level-4 pathogen, which is transmitted by specific types of fruit bats, mainly Pteropus spp. which are natural reservoir host. The disease was reported for the first time from the Kampung Sungai Nipah village of Malaysia in 1998. Human-to-human transmission also occurs. Outbreaks have been reported also from other countries in South and Southeast Asia. Phylogenetic analysis affirmed the circulation of two major clades of NiV as based on currently available complete N and G gene sequences. NiV isolates from Malaysia and Cambodia clustered together in NiV-MY clade, whereas isolates from Bangladesh and India clusterered within NiV-BD clade. NiV isolates from Thailand harboured mixed population of sequences. In humans, the virus is responsible for causing rapidly progressing severe illness which might be characterized by severe respiratory illness and/or deadly encephalitis. In pigs below six months of age, respiratory illness along with nervous symptoms may develop. Different types of enzyme-linked immunosorbent assays along with molecular methods based on polymerase chain reaction have been developed for diagnostic purposes. Due to the expensive nature of the antibody drugs, identification of broad-spectrum antivirals is essential along with focusing on small interfering RNAs (siRNAs). High pathogenicity of NiV in humans, and lack of vaccines or therapeutics to counter this disease have attracted attention of researchers worldwide for developing effective NiV vaccine and treatment regimens.

References 267

  1. 1.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/b978-0-444-53488-0.00032-8

  2. 2.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.3201/eid1012.040452

  3. 3.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.virusres.2013.08.002

  4. 4.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jcm.01875-17

  5. 5.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.apjtm.2016.05.012

  6. 6.
  7. 7.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  8. 8.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1111/pbi.12460

  9. 9.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1093/infdis/jiy612

  10. 10.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1007/82_2012_209

  11. 11.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1080/13550280500187435

  12. 12.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1177/1010539510370908

  13. 13.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1146/annurev-animal-030117-014628

  14. 14.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.4269/ajtmh.2009.80.96

  15. 15.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.79.11.6690-6702.2005

  16. 16.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1586/14787210.4.1.43

  17. 17.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.jviromet.2007.01.003

  18. 18.
  19. 19.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.meegid.2018.01.007

  20. 20.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.20506/rst.36.2.2687

  21. 21.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1371/journal.pone.0061316

  22. 22.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1007/82_2012_213

  23. 23.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.antiviral.2013.06.012

  24. 24.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.vaccine.2016.03.075

  25. 25.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  26. 26.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  27. 27.
  28. 28.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  29. 29.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1099/0022-1317-82-9-2151

  30. 30.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.13040/ijpsr.0975-8232.9(8).3128-35

  31. 31.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1186/1743-422x-3-47

  32. 32.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/s0140-6736(18)31252-2

  33. 33.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.01852-10

  34. 34.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.4103/jfmpc.jfmpc_137_18

  35. 35.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.jviromet.2006.05.003

  36. 36.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1186/1743-422x-7-115

  37. 37.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  38. 38.
  39. 39.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/s0140-6736(99)04299-3

  40. 40.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/s1386-6532(02)00268-8

All 267 references

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.